CN103384477B - For having the composition of the functional food recovering blood constitute and function - Google Patents
For having the composition of the functional food recovering blood constitute and function Download PDFInfo
- Publication number
- CN103384477B CN103384477B CN201280005658.0A CN201280005658A CN103384477B CN 103384477 B CN103384477 B CN 103384477B CN 201280005658 A CN201280005658 A CN 201280005658A CN 103384477 B CN103384477 B CN 103384477B
- Authority
- CN
- China
- Prior art keywords
- food composition
- healthy functions
- composition
- functions food
- phloroglucin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 96
- 210000004369 blood Anatomy 0.000 title abstract description 36
- 239000008280 blood Substances 0.000 title abstract description 36
- 235000013376 functional food Nutrition 0.000 title abstract description 4
- 229960001553 phloroglucinol Drugs 0.000 claims abstract description 23
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 19
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000011319 anticancer therapy Methods 0.000 claims abstract description 16
- 229920001864 tannin Polymers 0.000 claims abstract description 16
- 235000018553 tannin Nutrition 0.000 claims abstract description 16
- 239000001648 tannin Substances 0.000 claims abstract description 16
- 235000004431 Linum usitatissimum Nutrition 0.000 claims abstract description 14
- 102000008186 Collagen Human genes 0.000 claims abstract description 12
- 108010035532 Collagen Proteins 0.000 claims abstract description 12
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 12
- 229920001436 collagen Polymers 0.000 claims abstract description 12
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 12
- 229910052742 iron Inorganic materials 0.000 claims abstract description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 10
- 239000011575 calcium Substances 0.000 claims abstract description 10
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 9
- 239000011709 vitamin E Substances 0.000 claims abstract description 9
- 229940046009 vitamin E Drugs 0.000 claims abstract description 9
- 230000006870 function Effects 0.000 claims description 65
- 235000013305 food Nutrition 0.000 claims description 48
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 30
- 241000272814 Anser sp. Species 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 208000017667 Chronic Disease Diseases 0.000 claims description 6
- 230000003064 anti-oxidating effect Effects 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 5
- 235000014510 cooky Nutrition 0.000 claims description 5
- 235000005911 diet Nutrition 0.000 claims description 5
- 230000000378 dietary effect Effects 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 241000195493 Cryptophyta Species 0.000 claims description 4
- 150000002240 furans Chemical class 0.000 claims description 4
- 229930013686 lignan Natural products 0.000 claims description 4
- 235000009408 lignans Nutrition 0.000 claims description 4
- 150000005692 lignans Chemical class 0.000 claims description 4
- 239000011435 rock Substances 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 241000251468 Actinopterygii Species 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 208000036119 Frailty Diseases 0.000 claims description 3
- 206010003549 asthenia Diseases 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 2
- 235000008429 bread Nutrition 0.000 claims 1
- 230000035882 stress Effects 0.000 abstract description 7
- 230000007423 decrease Effects 0.000 abstract description 6
- 230000032683 aging Effects 0.000 abstract description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 36
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 27
- 229960002949 fluorouracil Drugs 0.000 description 26
- 230000000694 effects Effects 0.000 description 25
- 238000012360 testing method Methods 0.000 description 22
- 210000003743 erythrocyte Anatomy 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 18
- 229960003180 glutathione Drugs 0.000 description 17
- 108010024636 Glutathione Proteins 0.000 description 16
- 230000003078 antioxidant effect Effects 0.000 description 13
- 210000000265 leukocyte Anatomy 0.000 description 13
- 210000001772 blood platelet Anatomy 0.000 description 11
- 229940068196 placebo Drugs 0.000 description 11
- 239000000902 placebo Substances 0.000 description 11
- 102000016938 Catalase Human genes 0.000 description 9
- 108010053835 Catalase Proteins 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 9
- 230000036039 immunity Effects 0.000 description 9
- 238000012549 training Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 8
- 235000012054 meals Nutrition 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000036542 oxidative stress Effects 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- 238000002512 chemotherapy Methods 0.000 description 6
- 230000007123 defense Effects 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 102100037850 Interferon gamma Human genes 0.000 description 5
- 108010074328 Interferon-gamma Proteins 0.000 description 5
- 102000003777 Interleukin-1 beta Human genes 0.000 description 5
- 108090000193 Interleukin-1 beta Proteins 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 229940124650 anti-cancer therapies Drugs 0.000 description 5
- 235000012180 bread and bread product Nutrition 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 235000013312 flour Nutrition 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000208202 Linaceae Species 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 230000036765 blood level Effects 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- HSSLDCABUXLXKM-UHFFFAOYSA-N resorufin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3N=C21 HSSLDCABUXLXKM-UHFFFAOYSA-N 0.000 description 3
- 235000011803 sesame oil Nutrition 0.000 description 3
- 239000008159 sesame oil Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- WXHLLJAMBQLULT-UHFFFAOYSA-N 2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-n-(2-methyl-6-sulfanylphenyl)-1,3-thiazole-5-carboxamide;hydrate Chemical compound O.C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1S WXHLLJAMBQLULT-UHFFFAOYSA-N 0.000 description 2
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 2
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical group O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 108010053070 Glutathione Disulfide Proteins 0.000 description 2
- 108010063907 Glutathione Reductase Proteins 0.000 description 2
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229960004543 anhydrous citric acid Drugs 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- VDTNNGKXZGSZIP-UHFFFAOYSA-N carbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VDTNNGKXZGSZIP-UHFFFAOYSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000003176 neuroleptic agent Substances 0.000 description 2
- 230000000701 neuroleptic effect Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000003075 phytoestrogen Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- -1 synanthrin Chemical compound 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000272808 Anser Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 238000008998 Catalase assay kit Methods 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 229920002138 Eckol Polymers 0.000 description 1
- ARZMNZGBFNSOIR-UHFFFAOYSA-N Eckol Natural products OC1=CC(O)=C2OC3=CC(C)=CC(O)=C3OC2=C1OC1=CC(O)=CC(O)=C1 ARZMNZGBFNSOIR-UHFFFAOYSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010059024 Gastrointestinal toxicity Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010030216 Oesophagitis Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 1
- 229920003110 Primojel Polymers 0.000 description 1
- 206010036774 Proctitis Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108010022394 Threonine synthase Proteins 0.000 description 1
- 102000005497 Thymidylate Synthase Human genes 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000002364 anti-haemorrhagic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 231100001015 blood dyscrasias Toxicity 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 230000005880 cancer cell killing Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000021218 carrot soup Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- PCZZRBGISTUIOA-UHFFFAOYSA-N eckol Chemical compound OC1=CC(O)=CC(OC=2C=3OC4=C(O)C=C(O)C=C4OC=3C(O)=CC=2O)=C1 PCZZRBGISTUIOA-UHFFFAOYSA-N 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000006881 esophagitis Diseases 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 231100000414 gastrointestinal toxicity Toxicity 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000007887 hard shell capsule Substances 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002558 medical inspection Methods 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- PHAVZQMFQKARQX-UHFFFAOYSA-N phlorofucofuroeckol Natural products Oc1cc(O)c(Oc2c(O)cc(O)c3c2oc4cc(O)c5Oc6c(Cc7cc(O)cc(O)c7)c(O)cc(O)c6Oc5c34)c(O)c1 PHAVZQMFQKARQX-UHFFFAOYSA-N 0.000 description 1
- SLWPBUMYPRVYIJ-UHFFFAOYSA-N phlorofucofuroeckol a Chemical compound OC1=CC(O)=CC(OC=2C=3OC4=C(C=5C6=C(O)C=C(O)C(OC=7C=C(O)C=C(O)C=7)=C6OC=5C=C4O)OC=3C(O)=CC=2O)=C1 SLWPBUMYPRVYIJ-UHFFFAOYSA-N 0.000 description 1
- 229920001339 phlorotannin Polymers 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical group CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to for be effective to recover due to anticancer therapy, operation, aging or stress and the composition of functional food of the blood constitute and function of decline.Composition for functional food comprises the Cobastab of the collagen of (with dry weight) 30 ~ 90wt%, the linseed of 3 ~ 60wt%, the phloroglucin tannin of 1 ~ 50wt%, the calcium of 1 ~ 30wt%, the iron of 0.1 ~ 3wt%, the vitamin E of 0.01 ~ 0.5wt% and 0.01 ~ 0.1wt%.
Description
Technical field
The present invention relates to for have efficient recovery due to chemotherapy, operation, chronic disease, over training stress or healthy functions food that is aging and the serology constitute and function be lowered.
The application's book requires the rights and interests of the Korean Patent Application No. 10-2011-0003566 that on January 13rd, 2011 submits to, and its full content is incorporated to the application as a reference.
Background technology
In the past in many decades, develop much outstanding anticancer and anti-cancer therapies by chemical synthesis or by separating natural material.These effort significantly improve the cure rate of cancer in this in period.But concentrate on the damage of removing localized cancer, conventional cancer therapy causes the problem reducing patients ' life quality.In recent years, the deterioration needing the quality of life improving chemotherapy or radiotherapy induction is proposed.
Since nineteen fifty-seven synthetic chemistry therapeutic agent 5 FU 5 fluorouracil (5-FU) first, it for clinical practice so far.5-FU is transformed into active nucleotide in cancer cell, and Main Function is the effect stoping thymidylate synthase, thus DNA replication dna in inhibition cancer cell.This activating agent, clinically for wide spectrum cancer, comprises breast cancer, colorectal cancer, the carcinoma of the rectum, cancer of the stomach, prostate cancer, the cancer of the esophagus, liver cancer, head and neck cancer and carcinoma of urinary bladder, and also local is used for cutaneum carcinoma.But this activating agent causes significant side effect, comprises hematopoietic toxicity.In addition, 5-FU has negative effect to digestive system, causes high-frequency gastritis, esophagitis, rectitis, diarrhoea etc.And, find that the patient using 5-FU suffers melanocyte to increase disease.Except hematopoietic toxicity (such as Neuroleptic Leukocytopenia) and gastrointestinal toxicity (in such as intestinal mucosa, sucrose lacks and diarrhoea), report the side effect of immunotoxicity (such as spleen weight reduction, lymphocyte minimizing etc.) as 5-FU.
Other representative chemotherapeutic agents also been observed significant side effect, and described chemotherapeutant is adriamycin, bleomycin, mitomycin and cis-platinum such as.These activating agents of chronic administration cause reversible or irreversible DNA damage, such as, suppress DNA replication dna and cell division, cell membrane damage etc.
Report the cancer patient that the whole world is tens million of at present, and there is significant side effect in nearly all anti-cancer therapies being applied to them.Chemotherapy is usually designed to the cancer cell killing division fast, but also destroys the normal cell with the short cell cycle, such as haemocyte.In chemotherapy side effect, most is representative and have plenty of the blood function obstacle that hematoclasis causes altogether.Such as, patient is easy to reduced by decrease of platelet, Neuroleptic Leukocytopenia and immunity usually, and this causes quality of life to decline.
In radiotherapy, the radiation of high dose also causes leucocyte and platelet levels and immunity to reduce, and causes the Antioxidative Defense System dysfunction of blood.The operative treatment of cancer also has negative effect to blood health.In operation, medicine (such as whole body or local anesthetic, antihemorrhagic, anticoagulation and anodyne) and oxidative stress (the temporary transient imbalance of such as metabolism and temporary transient hemorrhagic ischemic) active oxygen classification (OH, NO must be produced
2deng), bring out side effect subsequently.
Therefore, recovering blood constitute and function (such as immunity and anti-oxidative defense) is very important for effectively getting well in the side effect from anti-cancer therapies and operation.In addition, the patient of chronic disease, the elderly, weakling and continuously and the people of over training shows the serology problem of unstable serology composition and low immunity or anti-oxidative defense function is suffered from.Recover blood constitute and function for a restorative prerequisite.
A lot of recovery meals are only suitable for providing enough required nutrients or polyphenoils, or comprise raw material, and its chemical composition is unknown (Korean patent No. 0722698,0591539 and 0355012).Korean patent No. 0519456 relates to the composition for suppressing anticancer therapy side effect, and it is designed to improve blood cell levels and immunity, and described haemocyte is leucocyte, red blood cell and blood platelet such as.But, composition to the anti-oxidative defense (important indicator of Health restoration) recovering to mention in this patent without any effect.In addition, because composition contains multiple grass, its composition is difficult to clear and definite standardization and in food.
For the present invention, the present inventor to the nutrition of Multiple components, herbal medicine with and biochemical property emphasis and thoroughly research obtain such discovery, generate, from blood, remove inflammatory factor and promote that blood antioxidant function can overcome the problem run in prior art as the concrete composition of the Multiple components of food, haemocyte, and be considered to as food composition for there being efficient recovery serology constitute and function to be very effective.
Open
Technical problem
In order to overcome the problem run in prior art, the object of this invention is to provide healthy functions food composition, it comprises the Cobastab of the collagen of 30 ~ 90wt%, the linseed of 3 ~ 60wt%, the phloroglucin tannin (phlorotannin) of 1 ~ 50wt%, the calcium of 1 ~ 30wt%, the iron of 0.1 ~ 3wt%, the vitamin E of 0.01 ~ 0.5wt% and 0.01 ~ 0.1wt%.
Another object of the present invention is to provide healthy functions food, and wherein based on the healthy functions food composition of 100 weight portions, the use amount of excipient is from 1 to 1,000 weight portion.
Technical scheme
According to an one aspect, the invention provides healthy functions food composition, it comprises the Cobastab of the collagen of 30 ~ 90wt%, the linseed of 3 ~ 60wt%, the phloroglucin tannin of 1 ~ 50wt%, the calcium of 1 ~ 30wt%, the iron of 0.1 ~ 3wt%, the vitamin E of 0.01 ~ 0.5wt% and 0.01 ~ 0.1wt%.
Before healthy functions food composition of the present invention can be applicable to just to experience anticancer therapy, experience anticancer therapy or after experience anticancer therapy, suffer chronic disease, the physically-draining that maybe stress cause due to over training or the individuality of senile debility.
In addition, healthy functions food composition of the present invention can be mixed with the form being suitable for absorbing, such as tablet, capsule, pill, granule, liquid, beverage, liquid dietary, soup, bread product, rod and cooky.
According to its another aspect, the invention provides the healthy functions food comprising excipient, based on the healthy functions food composition of 100 weight portions, the amount of excipient is from 1 to 1,000 weight portion.
Beneficial effect
When taking in, healthy functions food composition of the present invention may be used for improving the blood dyscrasia constitute and function obstacle that many factors (comprise medicine, stress wait) causes, thus in serology composition and anti-oxidative defense ability recovery blood to normal condition.
Best mode
The present invention is described below in detail.
According to an one aspect, the invention provides healthy functions food composition, it comprises the Cobastab of the collagen of 30 ~ 90wt%, the linseed of 3 ~ 60wt%, the phloroglucin tannin of 1 ~ 50wt%, the calcium of 1 ~ 30wt%, the iron of 0.1 ~ 3wt%, the vitamin E of 0.01 ~ 0.5wt% and 0.01 ~ 0.1wt%.
Collagen is the scleroprotein found in the bone of animal and cartilage and fish scale.It is the fibrillation form extended, and water insoluble, but is irreversibly hydrolyzed into gelatin when boiling.The feature of this protein is the proline of high-load, hydroxyproline and glycine.In the present invention, collagen is used as the stock that haemocyte generates, and as protein source, promotes the generation of albumin and immunoglobulin (Ig) in blood.If the use amount of collagen is less than 30wt%, its effect is not enough to play.On the other hand, unfavorable economically more than the collagen content of 90wt%.
Collagen used in the present invention derived from fish or meat, but can not limit it.
Flax is annual herb, and it is Dicotyledoneae Mang ox seedling order flax family (Linaceae) member, and has production from Europe to Argentina.The seed of flax, also referred to as linseed, is rich in phytoestrogen lignan and phytoprotein, and therefore they contribute to producing albumin and globulin, thus improve immunity.Linseed content is lower than the effect that can not obtain linseed during 3wt%.On the other hand, the composition containing the linseed being greater than 60wt% amount is difficult to be mixed with required form.
In the present invention, linseed can use as a powder or in liquid form, but does not limit it.
Phloroglucin tannin, the class tannin existed in brown alga is potential antioxidant, has the middle character between water and lipid solubility.Ability phloroglucin tannin being recovered to vascular function or removing inflammatory factor has a lot of report.
Phloroglucin tannin available in the present invention can be selected from but be not limited to goose palm dish phenol (eckol), two goose palm dish phenol, 6,6 '-bis-goose palm dish phenol, 8,8 '-bis-goose palm dish phenol, 2-O-(2,4,6-trihydroxy phenyl)-6,6 '-bis-goose slaps dish phenol, phloroglucin basement rock algae furans goose palm dish phenol (phlorofucofuroeckol), rock algae furans goose palm dish phenol (fucofuroeckol), 2-phloroglucin base goose palm dish phenol, 7-phloroglucin base goose slaps dish phenol, three phloroglucin base geese slap dish phenol, phloroglucin tannin A and combination thereof.
In the present invention, the effect of phloroglucin tannin is there is no when phloroglucin tannin amount is less than 1wt%.On the other hand, economic benefits is not had more than the phloroglucin tannin content of 50wt%.
Calcium, in periodic table Central Plains, subnumber is the alkaline-earth metal of 20, is the required inorganic nutritive element controlling body basic activity (such as blood clotting, contraction of muscle etc.).It is one of nutrient that in meals, most probable lacks, and for adult, its daily intake of recommending is 700mg.
Calcium content lower than 1wt% can not play enough calcium effects.On the other hand, when it contains the calcium higher than 30wt% amount, composition is difficult to be mixed with required form.
Iron is periodic table Central Plains subnumber is the metal of 26, and is used as required inorganic nutritive element, and it is that the physiology course of O_2 transport and cellular respiration is necessary, and plays a significant role in generation red blood cell.For adult female, the daily intake of the recommendation of iron is 12 ~ 15mg.
In the present invention, there is no effect when iron content is less than 0.1wt%, and make composition be difficult to be mixed with required form higher than the iron content of 3wt%, or negative effect is existed to the color of preparation or effective life.
Vitamin E, also referred to as tocopherol, as fat-soluble antioxidant.
When its amount is less than 0.01wt%, there is no obvious vitamin E effect, and easily produce toxicity more than the content of vitamin E of 0.5wt%.
There is the Cobastab of different subtype.It plays a significant role in immune system and cellular metabolism.In the present invention, there is no obvious effect when Cobastab amount is less than 0.01wt%, and there is negative effect more than the effective life of Cobastab content to preparation of 0.1wt%.
Healthy functions food composition of the present invention, except comprising the Cobastab of the collagen of 30 ~ 90wt%, the linseed of 3 ~ 60wt%, the phloroglucin tannin of 1 ~ 50wt%, the calcium of 1 ~ 30wt%, the iron of 0.1 ~ 3wt%, the vitamin E of 0.01 ~ 0.5wt% and 0.01 ~ 0.1wt%, can comprise the lecithin of 1 ~ 10wt%, the lignan of 0.005 ~ 3wt%, the copper of 0.01 ~ 0.2wt% further.
Lecithin is the key component of a kind of phosphatide, cell membrane, and is present in a large number in yolk, soya-bean oil, liver and brain.
Lignan is the adopted name of the natural products much with the structure formed by connecting two positive phenyl-propane residues on the beta carbon of n-pro-pyl side chain.It is phytoestrogen and is used as antioxidant.
Copper is the metallic element of periodic table Central Plains subnumber 29, and contributes to utilizing iron and producing red blood cell on physiology.For adult, the daily intake of recommendation is 1.5 ~ 3mg.
In one embodiment, in the mouse of using anticancer 5-FU, the level that composition of the present invention significantly increases the cytokine profiles related in blood platelet, leucocyte and red blood cell and immunologic facilitation is observed.
In another embodiment, be applied to team of institute 40 male sex's bicycle entrants during non-season strong training period after, have evaluated the ability that composition of the present invention recovers blood composition.Find the level significantly increasing white blood corpuscle, red blood cell, hemoglobin and hematid specific volume simultaneously.
Therefore, healthy functions food composition of the present invention can recover serology composition to normal level.
In order to assess healthy functions food composition of the present invention to the antioxidation of blood, monitor the level of biomarker of representative polyphenoils and MDA (MDA) in the glutathione of 40 male sex's bicycle entrants and catalase, blood, oxidative stress.Placebo is compared in discovery, and group glutathione and the catalase of using healthy functions food composition of the present invention add, but MDA reduces.
Therefore, healthy functions food composition of the present invention can recover the anti-oxidation function of blood to normal level.
Before healthy functions food composition of the present invention can be applicable to just to experience anticancer therapy, experience anticancer therapy or after experience anticancer therapy, suffer chronic disease, because excess body trains the individuality of physically-draining or the senile debility that maybe stress cause, but it is not limited.
In addition, healthy functions food composition of the present invention can be mixed with the form being suitable for absorbing, such as tablet, capsule, pill, granule, liquid, beverage, liquid dietary, soup, bread product, rod and cooky.
According to its another aspect, the invention provides the healthy functions food comprising excipient, based on the healthy functions food composition of 100 weight portions, figuration dosage is from 1 to 1,000 weight portion.
The example of excipient available in the present invention comprise glutinous rice, rice powder, flour, honey, avicel cellulose, silica, crystal diabetin, anhydrous citric acid, synanthrin, vitamin C, sesame oil, soy sauce, sugar, starch, gelatinized starch, microcrystalline cellulose, lactose, PVP, cataloid, calcium monohydrogen phosphate, sweet mellow wine, wheat gluten (wheat gluten), Arabic gum, pregelatinized starch, cornstarch, cellulose powder, hydroxypropyl cellulose,
, primojel, Brazil wax, the alumina silicate of synthesis, stearic acid, dolomol, aluminum stearate, calcium stearate, dextrose, sorbierite and talcum powder, but it not to be limited.Based on the composition of 100 weight portions, the preferred use amount of excipient from 1 to 1,000 weight portion, but does not limit it.
Invention mode
By the following example, the present invention may be better understood, described embodiment for illustration of, but restriction the present invention can not be interpreted as.
Preparation embodiment 1: the preparation of composition
Prepare the multiple combination thing that constituent content is different.
Table 1
Table 2
Preparation embodiment 2: preparation
Healthy functions food composition of the present invention can be mixed with the form being suitable for absorbing as follows.
1. the preparation of pill and picked-up
Glutinous rice, flour, honey and water are mixed with the weight ratio of 1:1:0.5:3, boils and be cooled to room temperature, obtain the soup of thickness.Described soup is mixed with composition 1 with the weight ratio of 1:9, and mixture kneading is become pill, each heavy 2g.Chew picked-up 2 ball (4g) every day after the meal.
2. the preparation of tablet and picked-up
Composition 2, lactose, avicel cellulose, silica and dolomol are mixed with the weight ratio of 35:25:37:1:1, and with tablet press machine, mixture is pressed into tablet (600mg).Every day absorbs 6 to 10 after the meal.
3. the preparation of beverage and picked-up
Composition 4, crystal diabetin, anhydrous citric acid, synanthrin, vitamin C and water are mixed with the weight ratio of 2:8:1:8:0.2:160, boils 5 minutes, stir simultaneously, and cool.The beverage that every day produces with amount twice picked-up of 180mL.
4. the preparation of congee and picked-up
Glutinous rice and rice powder are mixed with the weight ratio of 1:1, and boils into congee.In the hot congee of 200g, add 2g composition 6,0.5g sesame oil and 0.5g soy sauce, and be mixed together.Absorb the congee of twice generation every day, as meals.
5. the preparation of bread product and picked-up
By the mixture kneading of 250g flour, 30g butter, 6.5g yeast, 5g salt, 37.5g sugar, 130g water and 20g composition 9, mainly 37 DEG C of fermentations, and get 30g in square position.After expanding in bread product second time sweat, they are coated with setting egg(s), and cure 15 minutes in 180 DEG C of baking boxs.Absorb the bread product produced for twice or three times every day, as meals or edible between dining.
6. the preparation of capsule and picked-up
Composition 2 is mixed with dolomol with the weight ratio of 99.8:0.2, and mixture is loaded in hard shell capsules (gelatin) with 450mg amount.Absorb 3 to 9 capsules every day.
7. the preparation of liquid dietary and picked-up
Coarse rice powder, brown alga powder, carrot soup, salt, composition 10 and water are mixed with the weight ratio of 5:1:10:10:0.1:2:200, boils and be cooled to room temperature.The liquid dietary produced is supplied to patient by plastic tube.
8. the preparation of cooky and picked-up
By 80g butter melt, and with 100g sugar and 1 egg (50g) by being uniformly mixed.180g flour, yeast powder (1/2 or about 2.5mL) and sodium bicarbonate (1/2 or about 2.5mL) are sieved and joins in mixture.Subsequently, 12g composition 3 sieved and joins in mixture, then it being cured 15 minutes at 180 DEG C.Cooky is absorbed, every day 2 to 3 times between dining.
9. the preparation of rod and picked-up
40g butter is melted, and with 40g sesame oil, 100g sugar and 100g gelatin by being uniformly mixed.180g flour, yeast powder (1/2 or about 2.5mL) and sodium bicarbonate (1/2 or about 2.5mL) are sieved and joins in mixture together with 30g walnut.Then, add the 12g composition 5 after screening, and fully mix.Dough/pasta is of a size of 3cm with 70% volume loading wide, in the aluminium foil frame that 9cm is long and 2cm is dark, and cures 15 minutes in 180 DEG C of baking boxs.Between dining, every day absorbs 2 to 3 rods.
Embodiment 1: the recovery of serum analysis constitute and function in mouse model
The inhibit activities of the anti-5 FU 5 fluorouracil of analysed composition (5-FU) side effect, described 5-FU is one of the most widely used anticancer.C57BL/6 mouse is divided into and often organizes 10, and scrape off thin layer at right flank abdomen.B16-BL6 melanoma cells is contained 5 × 10 with 0.1mL
5~ 1 × 10
6the injected sc of individual cell gives every mouse.Inject latter 7 days, form obvious tumour in skin.Then, give every mouse by a shot in 5-FU peritonaeum, subsequently by the compound 4 of preparation in the Orally administered preparation embodiment 1 of zonde, dosage is 70mg/kg, once a day, and 7 days.Complete after using, by mouse fasting 1 day, weigh and anaesthetize.(put into containing 1.4%K from heart extracting blood sample
2in the pipe of EDTA), and count red blood cell (RBC), white blood corpuscle (WBC) and blood platelet (PLT) with Coulter counter (Coulter Corporation, USA).In addition, the level of immune cell factor is measured.In this, from mouse, take out peritoneal macrophages, and with 2.5 × 10
6the density in μ L/ hole, individual cell/500 is inoculated in 24-orifice plate, and cultivates 3 hours.Removing non-adherent cell.Cultivate after 48 hours, with the IL-1 β secreted in ELISA kit quantitative culture medium and IFN-γ.Result is outlined in following table 3.
Table 3
ap<0.05, relative negative control;
bp<0.01, relative negative control;
*p<0.05, relatively normally;
*p<0.01, relatively normally
As data are visible, compare normal control, reduce blood platelet (PLT) level 41% with 5-FU treatment separately.Compare and use separately 5-FU group, after healthy functions food composition of the present invention uses 7 days, platelet levels raises 41 ~ 58%.Therefore, find that healthy functions food composition of the present invention has recovered platelet levels to 83 ~ 93% of normal group.
For WBC, in the mouse of injecting separately 5-FU, observe WBC level decline 53%.Compare 5-FU group, use healthy functions food composition of the present invention after 7 days, WBC level raises 53 ~ 89%.Therefore, when with 5-FU combined administration, observe healthy functions food composition of the present invention and recovered WBC level to 72 ~ 89% of normal control values.
Injection 5-FU also can reduce RBC level 15%.Compare 5-FU group, in the group used together with healthy functions food composition of the present invention, RBC level significantly improves 12 ~ 15%.Therefore, when with 5-FU combined administration, observe healthy functions food composition of the present invention and recovered RBC level to 93 ~ 96% of normal control values.
For IL-1 β, the level observing it in the mouse of injecting separately 5-FU reduces by 48%.Compare 5-FU group, use healthy functions food composition of the present invention after 7 days, raise IL-1 β level 67 ~ 81%.Therefore, when with 5-FU combined administration, observe healthy functions food composition of the present invention and recovered IL-1 β level to 87 ~ 94% of normal control values.
Finally, inject 5-FU and reduce IFN-γ level 52%.Compare 5-FU group, in the group used together with healthy functions food composition of the present invention, IFN-γ level significantly improves 61 ~ 82%.Therefore, when with 5-FU combined administration, observe healthy functions food composition of the present invention and recover IFN-γ level to 77 ~ 86% of normal control values.
Consider in the lump, data show the blood constitute and function that composition of the present invention can have efficient recovery to damage due to anticancer 5-FU by the level of increasing serum component RBC, WBC and blood platelet and immune cell factor IL-1 β and IFN-γ.In addition, patient, the elderly and weakling after surgery and experience in chemotherapeutical patient and observe serology decline.Based on the result obtained, expect that those people (such as postoperative patient, the elderly etc.) that healthy functions food composition of the present invention dies down to health have effect above.
Embodiment 2: the recovery of analyzing blood composition and anti-oxidative defense potentiality in human body
When after accumulation, the exercise stress of high strength destroys red blood cell to produce higher speed than red blood cell, causes anaemia.And long-term high pressure training campaign reduces WBC level, causes immunity degradation.After long-term high pressure training campaign, although improve locomitivity, sportsman is easy to have with Post operation or experiences chemotherapy patients or the similar serology constitute and function of the elderly.Owing to observing the decline of ubiquitous serology constitute and function in those people of experience chemotherapy or experience operation and the elderly in direct sportsman after long-term high-intensity exercise, therefore, the ability that composition of the present invention recovers serology constitute and function can be assessed, if test implements with sportsman under the better condition controlled.In this, select 40 team of institute cyclist, and check serology constitute and function in high strength non-season training motion front and rear.In training period of encamping, they eat identical meals and carry out identical training program.Selected individuality within the previous moon, does not use any medicine and medical inspection is normal.Individuality is divided at random test group (n=20) and contrast (n=20).
All individualities are fully informed object and the method for this test in advance, and forbid eating outside predetermined meals, and forbid taking medicine.
Test trains between moving period in non-season to carry out one month.The composition 2 (every day 9 capsules, every capsules 450mg) of test group picked-up preparation embodiment 1 under the supervision of coach, 4 weeks.
Test example 1: blood sample collection and Serological testing
From fasting 8 hours or longer individuality, 10cc blood is gathered with disposable syringe.In the pipe that the blood sample that gathers from antecubital vein is loaded EDTA-process and serum separator tube.Obtain supernatant serum with 3,000rpm after centrifugal 15 minutes, and in whole blood and blood plasma, analyze other serology component.
Count blood cells, RBC, WBC and hemoglobin (Hb), and measure hematid specific volume (Hct).The antioxidase, particularly glutathione (GSH) in quantitative analysis blood, blood antioxidant defence potentiality are responsible for and catalase (CAT), and MDA (MDA), the biomarker of oxidative stress.
Test example 2: glutathione level
Measure the blood level of reduced glutathione (GSH) (indicants of blood antioxidant defence potentiality), as the difference between glutathione total in blood and oxidized form of glutathione level.
(reduced glutathione level=total glutathione level-oxidized form of glutathione level)
The glutathione blood level that following measurement is total.
Blood is mixed with 6% acetic acid and 10% sulfosalicylic acid, places several minutes, and with 5,000rpm centrifugal 5 minutes.Supernatant is again centrifugal, and by the supernatant dilution produced, with NADPH (nicotinamide-adenine dinucleotide phosphate, reduced form) and the DTNB (5 of predetermined amount, 5 '-two sulfo--two-(2-nitrobenzoic acid)) mixing, and 35 DEG C of incubations 5 minutes.Add the absorbance 2 minutes reading reactant mixture after the GR (glutathione reductase, Sigma G3664) of 50 μ L immediately at 412nm place.Total glutathione level is by using the measurement of GSH calibration curve to measure.
The blood level of following measurement oxidized form of glutathione (GSSG).
Blood sample is mixed with 6% acetic acid and 10% sulfosalicylic acid, places several minutes, and with 5,000rpm centrifugal 5 minutes.Supernatant is again centrifugal, and the supernatant produced and 2-VP (2-vinylpyridine, Sigma132292) are mixed by vigorous stirring, and incubation at room temperature 1 hour.By mixture diluted in buffer solution, and with NADPH and DTNB of predetermined amount 35 DEG C of incubations 5 minutes.Add the absorbance 3 minutes reading reactant mixture after the GR (glutathione reductase, Sigma G3664) of 50 μ L immediately at 412nm place.Oxidized form of glutathione level is by using the measurement of GSSG calibration curve to measure.
Test example 3: hydrogen peroxide enzyme level
Use catalase assay kit (A-22180, Molecular Probes) quantitative analysis catalase, catalase is the mark of blood antioxidant defence potentiality.When adding H in serum
2o
2during with HRP (horseradish peroxidase), Catalases catalyze is by H
2o
2be reduced into water, and HRP and H
2o
2reaction, forms resorufin, a kind of fluorescent material.Due to competition, highly active catalase reduces the signal of resorufin.The absorbance of resorufin is read at 570nm place.Hydrogen peroxide enzyme level is measured by using the measurement of (catalase) calibration curve.1U is defined as and can reduces 1 μm of ol H
2o
2enzyme amount.
Test example 4:MDA level
In order to quantitative MDA (MDA), the biomarker of oxidative stress in blood, mixes the serum of centrifugal acquisition with 10%TCA (trichloroacetic acid), boils 30 minutes in a water bath, cooling, and with 3000rpm centrifugal 10 minutes.Supernatant is mixed with 0.67%TBA (thiobarbituric acid), boils 30 minutes in a water bath, and with 3000rpm centrifugal 10 minutes.Use UV-spectrophotometer, read absorbance at 535nm place.Calibration curve is drawn with MDA-bis.
Table 4
to the restitution of serology composition
Group | Before picked-up | After absorbing 4 weeks | |
RBC(10 6/mm 3) | Test group | 4.72±0.28 | 4.88±0.22 a |
RBC(10 6/mm 3) | Placebo | 4.73±0.31 | 4.63±0.26 |
WBC(10 3/mm 3) | Test group | 7.24±1.44 | 7.02±1.16 a |
WBC(10 3/mm 3) | Placebo | 7.19±1.80 | 5.73±1.25 * |
Hb(g/dL) | Test group | 14.41±0.83 | 15.06±0.73 **a |
Hb(g/dL) | Placebo | 14.36±0.68 | 14.47±0.72 |
Hct(%) | Test group | 42.42±2.50 | 44.43±2.10 ** |
Hct(%) | Placebo | 42.27±2.13 | 42.30±1.86 |
ap<0.05, Versus Placebo;
*p<0.05, relatively before picked-up;
*p<0.01, relatively before picked-up
Non-season training motion is after 4 weeks, and in control group, RBC level reduces slightly, but significantly raises in the test group of picked-up composition of the present invention.For WBC, in control group, its level significantly reduces, but maintains in test group and be similar to initial level.Therefore, absorb composition energy Promote immunity power of the present invention to recover.In addition, observe the test group using composition of the present invention and significantly increase hemoglobin (Hb) level and hematid specific volume (Hct) level.Therefore, compositions table of the present invention reveals high haemocyte and generates active, as RBC level raise in further to prove.Therefore, composition of the present invention effectively can strengthen haemocyte generation and recover immunity.
Table 5
to the restitution of serum anti-oxidation function
ap<0.05, Versus Placebo;
*p<0.05, relatively before picked-up;
* *p<0.001, relatively before picked-up
For group (P<0.05) and period (P<0.001), there is significant difference in glutathione level.In prolonged exercise moves latter two group, blood glutathione level all increases, and test group is higher than placebo a lot.For group (P<0.05) and period (P<0.001), blood hydrogen peroxide enzyme level is also significantly different.After prolonged exercise motion, in two groups, blood hydrogen peroxide enzyme level all increases, and test group is higher than placebo a lot.
Placebo shows MDA level and significantly raises (P<0.05), but test group does not have.For group difference, placebo maintains significantly higher MDA level (P<0.05) than test group.When the oxidative stress accumulated due to prolonged exercise sports fatigue increases blood MDA level, the lower blood MDA horizontal attribution of test group is in such fact, and the picked-up present composition improves the anti-oxidation function that blood suppresses lipid oxidation.
Consider in the lump, the data obtained above show that the present composition can have efficient recovery serology anti-oxidation function, and reduce the serology oxidative stress under serious stressed condition.Therefore, expect that healthy functions food composition of the present invention helps patient, weakling, the elderly and sportsman to be recovered their health by the level increasing enzyme, described enzyme effectively can remove the multiple oxidative stress thing that anti-cancer therapies, chronic disease, aging, exercise stress etc. produce.
Claims (11)
1. healthy functions food composition, it comprises the collagen of 30 ~ 90wt%, the linseed of 3 ~ 60wt%, the phloroglucin tannin of 1 ~ 50wt%, the calcium of 1 ~ 30wt%, the iron of 0.1 ~ 3wt%, the vitamin E of 0.01 ~ 0.5wt% and the Cobastab of 0.01 ~ 0.1wt%, wherein phloroglucin tannin is selected from goose palm dish phenol, two goose palm dish phenol, 6, 6 '-bis-goose palm dish phenol, 8, 8 '-bis-goose palm dish phenol, 2-O-(2, 4, 6-trihydroxy phenyl)-6, 6 '-bis-goose palm dish phenol, phloroglucin basement rock algae furans goose palm dish phenol, rock algae furans goose palm dish phenol, 2-phloroglucin base goose palm dish phenol, 7-phloroglucin base goose palm dish phenol, three phloroglucin base goose palm dish phenol, phloroglucin tannin A and combination thereof.
2. the healthy functions food composition of claim 1, it comprises the copper of the lecithin of 1 ~ 10wt%, the lignan of 0.005 ~ 3wt% and 0.01 ~ 0.2wt% further.
3. the healthy functions food composition of claim 1, wherein collagen is derived from fish or meat.
4. the healthy functions food composition of claim 1, wherein linseed is powder or liquid form.
5. the healthy functions food composition of any one in Claims 1-4, it is for recovering serology composition or serology anti-oxidation function to normal level.
6. the healthy functions food composition of any one in Claims 1-4, its for just experience anticancer therapy, experience anticancer therapy before or experience anticancer therapy after, suffer chronic disease, because excess body trains the individuality of physically-draining or the senile debility that maybe stress cause.
7. the healthy functions food composition of any one in Claims 1-4, it is mixed with the form being selected from tablet, capsule, pill, granule, liquid, bread, rod and cooky.
8. the healthy functions food composition of any one in Claims 1-4, it is mixed with beverage.
9. the healthy functions food composition of any one in Claims 1-4, it is mixed with liquid dietary.
10. the healthy functions food composition of any one in Claims 1-4, it is mixed with congee.
11. healthy functions foods, wherein based on the healthy functions food composition of 100 weight portion claims 1, the use amount of excipient is from 1 to 1,000 weight portion.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110003566A KR101266889B1 (en) | 2011-01-13 | 2011-01-13 | Functional food compositions having the recovery effect of blood composition and function |
KR10-2011-0003566 | 2011-01-13 | ||
PCT/KR2012/000107 WO2012096475A2 (en) | 2011-01-13 | 2012-01-05 | Composition for a functional food having the effect of restoring blood composition and function |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103384477A CN103384477A (en) | 2013-11-06 |
CN103384477B true CN103384477B (en) | 2015-09-16 |
Family
ID=46507547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280005658.0A Active CN103384477B (en) | 2011-01-13 | 2012-01-05 | For having the composition of the functional food recovering blood constitute and function |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR101266889B1 (en) |
CN (1) | CN103384477B (en) |
WO (1) | WO2012096475A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102192712B1 (en) * | 2018-01-25 | 2020-12-18 | 주식회사 헤마스 | An animal feed composition comprising phlorotannin and product for animal |
US20220015403A1 (en) * | 2018-12-05 | 2022-01-20 | Botamedi Inc. | Composition for improving flavor of food, containing phlorotannin as active ingredient |
CN113068836A (en) * | 2021-05-14 | 2021-07-06 | 国家体育总局运动医学研究所 | Food-derived peptide and carbohydrate compositions for reducing acute exercise stress |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040095125A (en) * | 2003-05-06 | 2004-11-12 | 대한민국 (부경대학교총장) | Composition comprising phlorotannins isolated from the extract of Ecklonia stolonifera Okamura having anti-oxidative activity |
JP2008239619A (en) * | 2007-02-28 | 2008-10-09 | Fuji Chem Ind Co Ltd | Peripheral blood circulation ameliorative composition |
WO2010041832A2 (en) * | 2008-10-07 | 2010-04-15 | 부경대학교 산학협력단 | Antioxidant active composition containing an ishige okamurae-derived compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6261565B1 (en) * | 1996-03-13 | 2001-07-17 | Archer Daniels Midland Company | Method of preparing and using isoflavones |
-
2011
- 2011-01-13 KR KR1020110003566A patent/KR101266889B1/en active IP Right Grant
-
2012
- 2012-01-05 CN CN201280005658.0A patent/CN103384477B/en active Active
- 2012-01-05 WO PCT/KR2012/000107 patent/WO2012096475A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040095125A (en) * | 2003-05-06 | 2004-11-12 | 대한민국 (부경대학교총장) | Composition comprising phlorotannins isolated from the extract of Ecklonia stolonifera Okamura having anti-oxidative activity |
JP2008239619A (en) * | 2007-02-28 | 2008-10-09 | Fuji Chem Ind Co Ltd | Peripheral blood circulation ameliorative composition |
WO2010041832A2 (en) * | 2008-10-07 | 2010-04-15 | 부경대학교 산학협력단 | Antioxidant active composition containing an ishige okamurae-derived compound |
Non-Patent Citations (1)
Title |
---|
"间苯三酚对大鼠心脏缺血再灌注损伤保护作用及机制研究";李婷婷等;《中国优秀硕士学位论文全文数据库》;20110215;第27-29页 * |
Also Published As
Publication number | Publication date |
---|---|
KR20120082196A (en) | 2012-07-23 |
WO2012096475A3 (en) | 2012-11-29 |
KR101266889B1 (en) | 2013-05-24 |
WO2012096475A2 (en) | 2012-07-19 |
CN103384477A (en) | 2013-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN106983151A (en) | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof | |
CN108450756A (en) | One kind is reinforced the kidney bushing weight losing meal-replacing powder and preparation method thereof | |
JP2008174539A (en) | Healthy and functional food for obesity patient using purple-colored potato | |
CN108294231A (en) | It is suitble to the nutritional staple food of patients with diabetes mellitus | |
WO2018145664A1 (en) | Anti-fatigue composition for use in improving endurance performance | |
CN102273630A (en) | Red date composite health-care powder with effects of enriching blood and tonifying qi and preparation method thereof | |
CN103384477B (en) | For having the composition of the functional food recovering blood constitute and function | |
JP7007663B2 (en) | Kuro-moji extract | |
CN107530315A (en) | Energetic supersession activator in muscle cell | |
CN101766274A (en) | Antioxidant functional food composition containing bamboo-leaves flavones | |
CN104839679A (en) | Medical formula food for people with heart disease | |
Ali Redha et al. | Blackcurrants: A Nutrient-Rich Source for the Development of Functional Foods for Improved Athletic Performance | |
EP1656943A1 (en) | Extract from plant of japanese parsley family and process for producing the same | |
CN110574862A (en) | Nutritional weight-losing meal replacement powder suitable for teenagers and children and preparation method thereof | |
CN104839685A (en) | Medical formula food for people with wound, infection, operation, and at other emergency states | |
CN107397213A (en) | A kind of nutritional supplementation meal powder of diabetic | |
CN103005251A (en) | Dilapidated wall three-in-one type royal jelly product | |
CN103798596B (en) | Total nutrient formula food suitable for patients with cardiovascular and cerebrovascular diseases | |
JP6273440B2 (en) | GLP-1 production promoter, DPPIV inhibitor and glucose absorption inhibitor | |
KR20220125943A (en) | A composition for improving circulation of blood, antiinflammation, antiobesity and increasing function of immune comprising carrot leaf powder and broccoli powder | |
JP7156683B2 (en) | oral composition | |
JP2012082172A (en) | Dipeptidyl peptidase iv inhibitor containing schizandra chinensis water extract as active ingredient | |
KR101344564B1 (en) | Composition comprising extract of hot peppers and Chinese peppers for preventing or treating of obesity or hyperlipidemia | |
US20070003491A1 (en) | Body weight gain inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |